Back To: Home : Featured Technology : Functional Genomic Screening

CLICK HERE FOR WHAT'S NEW IN:
 

$140M big-data initiative underway in U.K.
June 2013
SHARING OPTIONS:

OXFORD, United Kingdom—The United Kingdom government and investor and philanthropist Li Ka Shing have joined together to form a $140 million initiative in big data and drug discovery. The undertaking will result in the Li Ka Shing Center for Health Information and Discovery, which is being built in two phases—the Target Discovery Institute and the Big Data Institute. The Target Discovery Institute, which is already complete, houses research that will generate disease data through the use of genomic and chemical screens, and is supported by several industry giants, including Pfizer Inc., Johnson & Johnson, Eli Lilly & Co., GlaxoSmithKline PLC, Novartis AG, Boehringer Ingelheim GmbH, AbbVie Inc. and Takeda Pharmaceutical Co., which have contributed $8 million for the Institute. The Big Data Institute will seek to develop ways to generate, store and analyze large datasets.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.